aap and FAME Medical Sign Acquisition Agreement

aap Implantate AG, a medical technology company listed in the Prime Standard Segment on the Frankfurt Stock Exchange, signed yesterday evening an acquisition agreement with the shareholders in the Dutch FAME Medical Group of Companies. aap is thereby acquiring by means of a pure stock transaction a group of four operating companies with a combined payroll of 110. They are EMCM (European Medical Contract Manufacturing), Bactimm Analytics, TPI (Tissue Processing International) and FMP (Fame Medical Products).

An extraordinary general meeting of aap Implantate AG shareholders is planned for mid-February 2007 to seek shareholders’ approval of the transaction and of the requisite capital increase.

aap’s Biomaterials division, which already accounts for 70% of aap Group sales, and the FAME companies very largely do business in the same segments (bone cements, bone replacement materials, tissue regeneration) but with a complementary product range. With the combination of the two groups, which have collaborated successfully for several years, aap will on the basis of a larger customer base and an extensive product pipeline position itself as a leading European provider in the fast-growing dental and orthopedic biomaterials market.

The combined companies anticipate consolidated sales of around EUR 30 million in 2007.